TriSalus Life Sciences director Gary B. Gordon reports acquisition of $22,000 in common shares
TLSI•Director Gary B. Gordon purchased 10,000 TriSalus Life Sciences shares at $2.20 each, increasing his direct beneficial ownership to 82,510 shares.
1. Share purchase
Gary B. Gordon purchased 10,000 shares of TriSalus Life Sciences common stock at $2.20 per share. His direct beneficial ownership rose to 82,510 shares following the purchase.




